Study of non needle injection on glycemia controlling and compliance in newly diagnosed type 2 diabetic patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028590

Enrollment

Unknown

Registered

2019-12-28

Start date

2020-01-10

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

Needle-free Injection:The subjects were hospitalized for 2 weeks. After discharge, the subjects were randomly divided into two groups: the non needle injection group (25 cases) and the needle injecti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) It is in accordance with WHO 1999 diagnosis criteria of diabetes mellitus; (2) Aged 18-40 years old; (3) The premixed insulin is used; (4)18Kg/m2 <= BMI<= 32Kg/m2 (5) HbA1c7.5%11%; (6) Have read and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Type 1 diabetes; (2) Secondary diabetic patients, such as acute pancreatitis, thyroid dysfunction, etc; (3) Acute and chronic complications of diabetes; (4) Heart, lung, liver and kidney failure, acute cardio cerebrovascular disease or serious sequelae; (5) Insulin allergy; (6) Confusion or language disorder; (7) Pregnancy and lactation; (8) Tumor patients, history of autoimmune diseases; (9) Those with irregular diet; (10) History of mental illness.

Design outcomes

Primary

Measure	Time frame
Blood Glucose;	—

Countries

China

Contacts

Public ContactXu Zhang

Department of Endocrinology, Shandong Provincial Hospital

zhangxu@medmail.com.cn+86 15168867279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026